Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | NM32-2668 |
Trade Name | |
Synonyms | |
Drug Descriptions |
NM32-2668 is a trispecific T-cell engager that targets ROR1, CD3epsilon, and human serum albumin, which potentially induces T-cell proliferation and activation and tumor cell lysis (Journal for ImmunoTherapy of Cancer 2021;9). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NM32-2668 | NM32-2668 | 0 | 1 |